Editor's note - Express Pharma

The quest for quality continues

Compliance, competition could be speed breakers

FDC ban exposes fault lines once again

Finding the right balance for nutraceuticals

Revised Schedule M audits to test will, skill of regulators and regulated

CDSCO cracks down on export licenses, antibiotic approvals

Some action points for the next PM

A step towards global harmonisation of GMP inspection protocols

Transition times in the pharma universe

Decoding the skirmish over revised Schedule M